Table 3.
Blood cell counts and basic coagulation parameters on admission
| Parameters on admission | Total cohort (n = 62) | Survivors (n = 51) | Nonsurvivors (n = 11) | P | ICU (n = 31) | Non-ICU (n = 31) | P |
| Platelets (x103/μl) | 216 (166.7–279.7) | 218 (175–286) | 179 (97–223) | 0.03∗ | 188 (156–245) | 233 (187–298) | 0.03∗ |
| Leucocytes (x103/μl) | 7.2 (5.3–10.6) | 7.3 (5.4–10.5) | 6.9 (3.2–11.4) | 0.37 | 6.9 (4.6–11.4) | 7.3 (5.4–8.8) | 0.82 |
| Neutrophils (x103/μl) | 5.5 (3.6–9.5) | 5.4 (3.9–9.8) | 6.1 (1.7–9.4) | 0.38 | 6.1 (3.4–10.2) | 5.1 (3.8–7.8) | 0.52 |
| Lymphocytes (x103/μl) | 0.7 (0.6–1.0) | 0.8 (0.6–1.1) | 0.6 (0.4–0.9) | 0.04∗ | 0.6 (0.4–0.9) | 0.9 (0.7–1.2) | 0.01∗ |
| PT (s) | 13.5 (12.6–14.4) | 13.5 (12.5–14.3) | 13.4 (13–14.6) | 0.85 | 13.4 (12.5–14.6) | 13.5 (12.6–14.3) | 0.93 |
| INR | 1.1 (1.0–1.2) | 1.1 (1.0–1.2) | 1.1 (1.0–1.2) | 0.61 | 1.1 (1.0–1.2) | 1.1 (1.0–1.2) | 0.87 |
| APTT (sec) | 30.7 ± 3.8 | 30.4 ± 3.5 | 31.6 ± 4.8 | 0.36 | 30.7 ± 4.5 | 30.6 ± 2.9 | 0.98 |
| Fibrinogen (mg/dl) | 745 ± 174.8 | 733.8 ± 185.6 | 890 ± 101.4 | 0.25 | 739.9 ± 189.4 | 751.4 ± 161.9 | 0.79 |
| D-dimer (ng/ml) | 390 (233–979) | 388 (234–1060) | 435 (190–895) | 0.93 | 435 (251–2486) | 289 (230–659) | 0.16 |
Data are presented as mean ± standard deviation for normally distributed variables and as median (interquartile range) for nonnormally distributed variables.
APTT, activated partial thromboplastin time; INR, international normalized ratio; PT, prothrombin time.
∗
indicates statistical significance (p < 0.05).